Janett Fischer

8PUBLICATIONS
25CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyImmunogenetics (incl. genetic immunology)Cancer geneticsMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 03, 2025
Soluble Urokinase Plasminogen Activator Receptor Predicts Survival and Hepatic Decompensation in Advanced Hepatocellular Carcinoma.

Fabian Artusa, Sven Lamatsch, Minh Duc Phan

|Sep 28, 2024
Prospective Analysis of Safety and Efficacy of Tenofovir Alafenamide Fumarate (TAF) in European Real-World Patients with Chronic Hepatitis B: A Single-Centre Real-Word Cohort Study.

Balazs Fülöp, Janett Fischer, Magdalena Hahn

|Aug 11, 2023
Sex-differences in the association of interleukin-10 and interleukin-12 variants with the progression of hepatitis B virus infection in Caucasians.

Janett Fischer, Eleni Koukoulioti, Tobias Müller

|Jan 21, 2023
Association of Common Polymorphisms in the Interleukin-1 Beta Gene with Hepatocellular Carcinoma in Caucasian Patients with Chronic Hepatitis B.

Janett Fischer, Shuang Long, Eleni Koukoulioti

|Jan 08, 2023
Association of Alpha-1 Antitrypsin Pi*Z Allele Frequency and Progressive Liver Fibrosis in Two Chronic Hepatitis C Cohorts.

Victoria Therese Mücke, Janett Fischer, Marcus Maximilian Mücke

|Nov 11, 2022
The Liver Maximum Capacity Test (LiMAx) Is Associated with Short-Term Survival in Patients with Early Stage HCC Undergoing Transarterial Treatment.

Janett Fischer, Stella Wellhöner, Sebastian Ebel

Pageof 2

Frequent Collaborators

6 joint publications

Thomas Berg

5 joint publications

Thomas Berg

2 joint publications

Eleni Koukoulioti

1 joint publications

Hans Dieter Nischalke